Valeant Pharmaceuticals International, Inc. (TSE:VRX – Get Free Report) (NYSE:VRX)’s share price traded down 3.3% on Monday . The stock traded as low as C$30.75 and last traded at C$30.80. 1,232,408 shares were traded during trading, a decline of 11% from the average session volume of 1,382,994 shares. The stock had previously closed at C$31.86.
Valeant Pharmaceuticals International Price Performance
The firm has a 50 day simple moving average of C$30.80.
Valeant Pharmaceuticals International Company Profile
Valeant Pharmaceuticals International, Inc operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S.
Further Reading
- Five stocks we like better than Valeant Pharmaceuticals International
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Momentum Trades for October With Ample Upside Ahead
- With Risk Tolerance, One Size Does Not Fit All
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- What Are Dividend Contenders? Investing in Dividend Contenders
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Receive News & Ratings for Valeant Pharmaceuticals International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals International and related companies with MarketBeat.com's FREE daily email newsletter.